Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Letter to the Editor

Simple Processing of Formalin-Fixed Paraffin-Embedded Tissue for Accurate Testing with the Xpert MTB/RIF Assay

Indre Budvytiene, Niaz Banaei
Geoffrey A. Land, Editor
Indre Budvytiene
aClinical Microbiology Laboratory, Stanford University Medical Center, Palo Alto, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Niaz Banaei
aClinical Microbiology Laboratory, Stanford University Medical Center, Palo Alto, California, USA
bDepartment of Pathology, Stanford University School of Medicine, Stanford, California, USA
cDepartment of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoffrey A. Land
Carter BloodCare & Baylor University Medical Center
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.01905-19
  • Article
  • Info & Metrics
  • PDF
Loading

LETTER

Extrapulmonary tuberculosis (TB) is a common presentation of TB, accounting for 15% of new TB cases in 2018 (1). Under routine practice, tissue biopsy specimens are often sent for histopathology without concurrent mycobacterial culture or nucleic acid amplification testing (NAAT). This leaves formalin-fixed paraffin-embedded tissue (FFPET) as the only viable specimen type for TB testing in these cases. Although TB NAAT can be performed on FFPET, it requires commercial extraction kits with cumbersome deparaffinization and extraction steps (2, 3).

The Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA) is a widely used, automated sample-to-answer, cartridge-based real-time PCR assay approved by the U.S. FDA for accurate detection of Mycobacterium tuberculosis in sputum (4). Studies have also shown high sensitivity of the Xpert MTB/RIF assay on fresh tissue (5). While processing of fresh specimens for testing with the Xpert MTB/RIF assay is relatively simple, a simple processing method for FFPET specimens is lacking, and most studies have shown poor performance for the Xpert MTB/RIF assay with FFPET (6–10). The aim of this communication is to describe a simple protocol for FFPET processing and testing with the Xpert MTB/RIF assay and evaluate its performance on FFPET from patients with suspected TB.

Depending on the size of the tissue in the block, three to five 10-μm sections of FFPET were transferred to a clean 2-ml tube. The scrolls were submerged in 400 μl of buffer ATL (Qiagen GmbH, Hilden, Germany) and incubated at 75°C for 5 min to melt the paraffin. The tube was spun at 6,000 × g for 10 sec to sediment the tissue, and 40 μl of proteinase K >600 mAU/ml (Qiagen GmbH) was added. The tube was vortexed for few seconds at medium speed and incubated for 16 h at 56°C. The tube was then spun at 6,000 × g for 10 sec and incubated at room temperature for 5 min to allow paraffin to solidify on the surface. Using a 1-ml pipette tip, a hole was punched through the surface waxy layer, and the entire liquid phase (∼440 μl) was transferred to a new tube containing 1 ml of Xpert MTB/RIF sample reagent. After vortexing for 30 sec, the entire volume (∼1.440 ml) was transferred to an Xpert MTB/RIF cartridge and tested per the manufacturer’s instructions. Sensitivity and specificity of the Xpert assay was determined using a lab-developed M. tuberculosis PCR test as the reference method (2).

In total, 61 FFPET samples sent to the Stanford Health Care Clinical Microbiology laboratory for M. tuberculosis PCR testing based on presence of granulomatous inflammation on histopathology with or without acid-fast bacilli were included in this study. Tissue sources included lung (n = 21), lymph node (n = 15), bone and joint (n = 5), genitourinary (n = 5), intra-abdominal (n = 5), gastrointestinal (n = 4), bone marrow (n = 1), and other (n = 5) samples. FFPET samples were tested with a reference M. tuberculosis PCR assay and the Xpert MTB/RIF assay, with the former prioritized for clinical testing. Sensitivity and specificity of the Xpert MTB/RIF assay were 85.7% (36/42) and 100% (19/19), respectively. All 6 of the FFPET blocks with false-negative results were reextracted and retested, and 3 tested positive. This suggests that sampling error may have contributed to lower sensitivity with the Xpert MTB/RIF assay. Exhaustion of tissue in the block may also be a contributing factor. Another explanation may be the fact that the reference PCR assay targets the multicopy insertion sequence IS6110, whereas the Xpert MTB/RIF assay targets the single-copy rpoB. Thus, the Xpert MTB/RIF Ultra assay, which targets IS6110 and another insertion sequence (IS1081), may prove more sensitive when used with our processing protocol. In addition, the lower sensitivity observed with the Xpert assay may be inherent to its extraction methodology. The Xpert MTB/RIF cartridge is designed to extract DNA from intact bacteria. Thus, free M. tuberculosis DNA resulting from tissue sectioning may be lost during extraction. The extent to which this contributed to lower sensitivity is unknown.

The FFPET protocol described in this study yielded a higher sensitivity than those reported by other studies using the Xpert assay (6–10). The reason for the higher sensitivity with our protocol is unclear, but it is likely independent of patient sample selection and more related to processing steps and the selection of reagents. The Qiagen buffer ATL used in our protocol is a proprietary tissue lysis buffer for use in purification of nucleic acids. In addition to buffer ATL, we evaluated Qiagen buffer G2, which is the recommended buffer for extraction of nucleic acids from FFPET. Interestingly, only buffer ATL proved effective when FFPET was tested with the Xpert assay in our laboratory. However, we do not know exactly how it contributed to improved sensitivity and whether it can be replaced with an alternative lysis buffer.

In summary, we describe a simple processing method for preparation of FFPET for testing with the Xpert MTB/RIF assay. Availability of this protocol will further expand application of the Xpert assay for simple and rapid diagnosis of TB from FFPET.

ACKNOWLEDGMENT

We thank the Clinical Microbiology laboratory staff for their assistance.

  • Copyright © 2020 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    World Health Organization. 2019. Global tuberculosus report 2019. World Health Organization, Geneva, Switzerland. https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf?ua=1.
  2. 2.↵
    1. Luo RF,
    2. Scahill MD,
    3. Banaei N
    . 2010. Comparison of single-copy and multicopy real-time PCR targets for detection of Mycobacterium tuberculosis in paraffin-embedded tissue. J Clin Microbiol 48:2569–2570. doi:10.1128/JCM.02449-09.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Schaumburg F,
    2. Peters G,
    3. Wardelmann E,
    4. Becker K,
    5. Sperveslage J
    . 2017. Evaluation of GenoType MTBDRplus by use of extracted DNA from formalin-fixed paraffin-embedded specimens. J Clin Microbiol 55:3300–3302. doi:10.1128/JCM.01410-17.
    OpenUrlFREE Full Text
  4. 4.↵
    1. Steingart KR,
    2. Sohn H,
    3. Schiller I,
    4. Kloda LA,
    5. Boehme CC,
    6. Pai M,
    7. Dendukuri N
    . 2013. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 1:CD009593. doi:10.1002/14651858.CD009593.pub2.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Kohli M,
    2. Schiller I,
    3. Dendukuri N,
    4. Dheda K,
    5. Denkinger CM,
    6. Schumacher SG,
    7. Steingart KR
    . 2018. Xpert(R) MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. Cochrane Database Syst Rev 8:CD012768.
    OpenUrlCrossRef
  6. 6.↵
    1. McMillen T,
    2. Usiak SC,
    3. Chen LH,
    4. Gomez L,
    5. Ntiamoah P,
    6. Hameed MR,
    7. Budvytiene I,
    8. Banaei N,
    9. Kamboj M,
    10. Babady NE
    . 2018. Evaluation of the Xpert MTB/RIF performance on tissues: potential impact on airborne infection isolation at a tertiary cancer care center. Infect Control Hosp Epidemiol 39:462–466. doi:10.1017/ice.2018.7.
    OpenUrlCrossRef
  7. 7.↵
    1. Njau AN,
    2. Gakinya SM,
    3. Sayed S,
    4. Moloo Z
    . 2019. Xpert MTB/RIF assay on formalin-fixed paraffin-embedded tissues in the diagnosis of extrapulmonary tuberculosis. Afr J Lab Med 8:748. doi:10.4102/ajlm.v8i1.748.
    OpenUrlCrossRef
  8. 8.↵
    1. Polepole P,
    2. Kabwe M,
    3. Kasonde M,
    4. Tembo J,
    5. Shibemba A,
    6. O'Grady J,
    7. Kapata N,
    8. Zumla A,
    9. Bates M
    . 2017. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues. Int J Mycobacteriol 6:87–93. doi:10.4103/2212-5531.201892.
    OpenUrlCrossRef
  9. 9.↵
    1. Rindi L,
    2. Ali G,
    3. Fabiani B,
    4. Fontanini G,
    5. Garzelli C
    . 2017. Detection of Mycobacterium tuberculosis from paraffin-embedded tissues by GeneXpert MTB/RIF. Tuberculosis (Edinb) 106:53–55. doi:10.1016/j.tube.2017.06.005.
    OpenUrlCrossRef
  10. 10.↵
    1. Yağmur G,
    2. Albayrak N,
    3. Daş T,
    4. Yıldırım M,
    5. Ozgün A,
    6. Büyük Y
    . 2014. Comparison of two different real-time PCR systems in postmortem diagnosis of tuberculosis in paraffin-embedded tissues. Mikrobiyol Bul 48:577–584. doi:10.5578/mb.8299.
    OpenUrlCrossRef
PreviousNext
Back to top
Download PDF
Citation Tools
Simple Processing of Formalin-Fixed Paraffin-Embedded Tissue for Accurate Testing with the Xpert MTB/RIF Assay
Indre Budvytiene, Niaz Banaei
Journal of Clinical Microbiology Feb 2020, 58 (3) e01905-19; DOI: 10.1128/JCM.01905-19

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Simple Processing of Formalin-Fixed Paraffin-Embedded Tissue for Accurate Testing with the Xpert MTB/RIF Assay
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Simple Processing of Formalin-Fixed Paraffin-Embedded Tissue for Accurate Testing with the Xpert MTB/RIF Assay
Indre Budvytiene, Niaz Banaei
Journal of Clinical Microbiology Feb 2020, 58 (3) e01905-19; DOI: 10.1128/JCM.01905-19
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • ACKNOWLEDGMENT
    • REFERENCES
  • Info & Metrics
  • PDF

KEYWORDS

formalin fixed
formalin-fixed paraffin-embedded tissue
Mycobacterium tuberculosis
Xpert

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X